Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Age (< 50 vs. ≥ 50) | 1.031 | 0.670–1.231 | 0.747 | |||
Tumor size (< 20 vs. ≥ 20) (mm) | 2.918 | 1.554–4.609 | < 0.001* | 1.895 | 0.881–2.805 | 0.493 |
TNM stage (I-II vs. III) | 1.732 | 1.275–2.618 | 0.013* | 1.787 | 1.271–2.991 | 0.015* |
Histological differentiation (I-II vs. III) | 1.078 | 0.487–1.499 | 0.718 | |||
Positive lymph node ratio (< 0.21 vs. ≥ 0.21) | 2.004 | 0.812–2.260 | 0.083 | |||
ER (pos vs. neg) | 0.714 | 0.513–1.919 | 0.057 | |||
PR (pos vs. neg) | 0.721 | 0.486–1.542 | 0.501 | |||
Herb2 (pos vs. neg) | 1.405 | 1.207–2.711 | 0.029* | 1.193 | 0.814–2.569 | 0.807 |
PD-L1 expression (pos vs. neg) | 0.610 | 0.352–0.903 | < 0.001* | 0.569 | 0.318–0.830 | < 0.001* |
TNBC (yes vs. no) | 1.902 | 0.890–2.925 | 0.604 |
HR Hazard ratio, CI Confidence interval, *Statistically significant, p < 0.05